TPO and autoimmune thrombocytopenic purpura: For persistent, chronic or recurrent ITP, the three most common treatments physicians would prescribe were TPO‐RAs (80%; n = 377/472), anti‐CD20 (76%; n = 357/472), and ”other immunosuppressants” (55%; n = 260/472).